Montreal, Canada-based @CaprionBioSci announced the CRO will rebrand as CellCarta. The move follows the 2019 merger between Caprion and HistoGeneX, a Belgian histopathology and genomics lab. Read more at xtalks.com/caprion-become…

While the approval pathway for #biosimilar products was established 12 years ago, there are still misconceptions about biosimilarity versus interchangeable status. U.S. FDA clears up these misconceptions and more at xtalks.com/biosimilars-vs…

Individuals with #dementia are two times more likely to contract #COVID19 than patients without cognitive impairment. And African Americans with dementia face an even higher risk. Read more about the research from Case Western Reserve at xtalks.com/patients-with-…

Sustainable #foodpackaging is on consumers' minds. 76% of millennials have a more favourable opinion of companies that exclusively use recyclable packaging and 64% are willing to pay more for it. Read about your best options for sustainable packaging at: xtalks.com/flexible-food-…

Let's honor yesterday's trailblazers and today's innovators by celebrating #WomeninScience

Are face masks contributing to #dryeyedisease? Find out what eye care experts are saying at xtalks.com/why-mask-assoc… #optometry

Looking for a new #podcast to listen to? Check out the weekly Xtalks #LifeScience Podcast for thought-provoking discussions on topics like the biggest cancer biotech acquisitions of 2021 so far, and why COVID-19 vaccine efficacies can't be compared. bit.ly/3vUI7Hf

Check out the Xtalks Food Podcast to get your weekly fix on the latest in the #foodindustry. We tackle topics like the market for CBD-infused beverages and what it means to be a carbon-neutral food company. Listen now wherever you get your podcasts! bit.ly/2NWw3Eb

Got #cybersickness from too much screen time? Give your eyes a break and listen to the latest episode of the Xtalks Webinars Life Science #Podcast! bit.ly/3dkNV48

Heavy metals in #babyfood and Pepsi's newest permanent flavor in this episode of the Xtalks Food Podcast. Listen now at bit.ly/3dwycPM

A lot can change in two years, and that's certainly true for these 6 #Parkinsons biotechs. Read about their clinical programs and how these companies have weathered the pandemic at bit.ly/2RlpY5m #ParkinsonsAwarenessMonth #KnowMorePD

This is like buying half of a life vest, and thinking that’s good enough to jump in a lake. Get your second shot. nytimes.com/2021/04/25/bus…

Think Google Translate is accurate enough to translate patient-reported outcomes instruments? Think again. Here's why linguistic validation is a better way to foster #patientdiversity in trials. bit.ly/3aRGOQo

Today is #ClinicalTrialsDay 2021. In a year marked by a global pandemic and massive changes in #clinicalresearch, here is what five insiders are saying about the state of the industry. Read more by Ayesha Rashid & Sarah Hand buff.ly/3tZbea4 #CTD2021 #ICTD2021 #COVID19

African Americans are 2X as likely to be diagnosed with dementia, so why do they make up just 5% of all clinical trial participants? Read more about how researchers are tackling this disparity at buff.ly/3ia21cr by Sarah Hand #AAIC21 #ENDALZ #dementia #Alzheimer

“As we’ve learned from this #COVID19 pandemic, antimicrobial resistance is a global challenge and it’s not just any particular country’s problem,” says infectious disease expert Dr. Daniel F. Sahm. #AMR #antibiotics #publichealth bit.ly/2XrGsfh

Those involved in #Alzheimers clinical trials will have to make some difficult decisions in the wake of the approval of aducanumab. Read what the experts are saying is necessary to maintain trial continuity and patient safety. #AAIC21 bit.ly/3B6Z9Dv

xtalks.com/seize-the-nigh…

I’m excited to attend #AAIC23 in July! Join me at the largest and most influential international meeting dedicated to advancing dementia science, featuring over 600 podium presentations across more than 100 sessions. Register today! i.snoball.it/p/iv1y/t

In this episode, Xtalks’ Editor-in-Chief Sarah Hand interviews @Braeburnrx's Chief Medical Officer Joshua Cohen, MD/MPH about the approval of #Brixadi for #opioidusedisorder and explains the technology behind its extended-release formula. 🔗 buff.ly/3ObF9YT